MC4R and diabetes mellitus: Although not directly related to diabetes, the use of liraglutide in people with prediabetes due to olanzapine‐ or clozapine‐treated schizophrenia did not change bone turnover markers.(45) Atrial that involved obese people with and without an MC4R mutation, it was observed that the control group exhibited an increase in bone mass (measured by mineral apparent density) in response to liraglutide treatment.